A phase III trial of thymosin beta-4 in patients with epidermolysis bullosa

Trial Profile

A phase III trial of thymosin beta-4 in patients with epidermolysis bullosa

Not yet recruiting
Phase of Trial: Phase III

Latest Information Update: 14 Feb 2018

At a glance

  • Drugs Thymosin-beta-4 (Primary)
  • Indications Epidermolysis bullosa
  • Focus Therapeutic Use
  • Sponsors G-treeBNT; ReGenTree
  • Most Recent Events

    • 14 Feb 2018 Planned initiation date changed from 1 Jul 2017 to 1 Jan 2018, according to a RegeneRx Biopharmaceuticals media release.
    • 14 Feb 2018 According to a RegeneRx Biopharmaceuticals media release, the trial is expected to initiate in 2018.
    • 01 Mar 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top